Analyst Reco. UCB SA OTC Markets

Equities

Delayed OTC Markets Other stock markets 11:25:13 16/07/2024 pm IST			5-day change	1st Jan Change
77.73 ^USD	-0.77%		-0.10%	+78.28%

20/06	Kepler Cheuvreux Downgrades UCB to Hold from Buy, Raises PT	MT
13/06	UCB Announces New CIMZIA® Data for Women Living with Chronic Rheumatic Diseases Throughout Pregnancy, and for People Living with Ra and High Rheumatoid Factor Levels	CI

Kepler Cheuvreux Downgrades UCB to Hold from Buy, Raises PT	20/06	MT
Berenberg Reiterates UCB's Purchase Rating, Raises PT	11/04	MT
UCB : Berenberg, Buy, raises its price target	11/04	CF
UCB : UCB all set to reach new highs	08/03
UCB : H2 beat; the prospects remain encouraging	28/02
UCB : H1 surpassed expectations, Bimzelx’s US approval much-awaited in Q3	31/23/31
UCB : Turnaround delayed but hope remains intact	20/23/20
UCB : Exceeded 2022 expectations; promising prospects, despite muted 2023 guidance	22/23/22
Roche’s Alzheimer’s failure has sector-wide implications	14/22/14
UCB : Decent H1 overshadowed by future uncertainties	02/22/02
UCB : 2021 results: a major confidence reinforcing event	25/22/25
ANALYST RECOMMENDATIONS : Chevron, Cisco, Dollar Tree, The Gap, Salesforce...	24/21/24
ANALYST RECOMMENDATIONS : Activision Blizzard, Beyond Meat, Britvic, Las Vegas Sans, Unilever...	16/21/16
ANALYST RECOMMENDATIONS : AstraZeneca, Designer Brands, Homeserve, Rio Tinto, Trane Technologies...	02/21/02
UCB : Pricing & pandemic concerns impede upward revision to full-year outlook, despite strong H1	02/21/02
ANALYST RECOMMENDATIONS : Baidu, Canopy Growth, General Motors, Laredo Petroleum, Rolls-Royce...	09/21/09
UCB : Encouraging long-term outlook	02/21/02
Exane Health Care Leaders Forum	12/18/12	FA
Berenberg Bank European Conference	06/17/06	FA
Berenberg Bank European Conference	02/15/02	FA

No results for this search

UCB : UCB all set to reach new highs

March 08, 2024 at 09:40 pm IST